Drug recall · December 26, 2012
Nalbuphine HCl Injection recall
Why: Lack of Assurance of Sterility: Complains of a loose crimp applied to the fliptop vial; and a missing stopper and flip cap were received and therefore sterility cannot be assured.
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
Nalbuphine HCl Injection, 20 mg/mL, 10 mL Multiple-dose Fliptop Vial, Rx only, Hospira, Inc., Lake Forest, IL 60045, NDC 0409-1467-01
- Lots / codes
Lot #: 11-293-DK, Exp 05/01/13
- Quantity
- 145,400 vials
- Company
- Hospira, Inc., Lake Forest, IL
- Distribution
- Nationwide and Puerto Rico.
- Initiated
- November 21, 2012 · Voluntary: Firm initiated
- Classified
- December 20, 2012
- Reported
- December 26, 2012
- Ended
- June 3, 2014
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Nalbuphine
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.